Daily Stock Analysis, CCM, Concord Medical Services Holdings Ltd, priceseries

Concord Medical Services Holdings Ltd. Daily Stock Analysis
Stock Information
Open
3.00
Close
3.01
High
3.01
Low
3.01
Previous Close
3.04
Daily Price Gain
-0.03
YTD High
3.60
YTD High Date
Jan 23, 2019
YTD Low
2.92
YTD Low Date
Jan 18, 2019
YTD Price Change
-0.55
YTD Gain
-15.45%
52 Week High
4.20
52 Week High Date
Jul 6, 2018
52 Week Low
2.46
52 Week Low Date
Feb 15, 2018
52 Week Price Change
0.44
52 Week Gain
16.92%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 6. 2018
2.67
Mar 23. 2018
3.02
13 Trading Days
13.08%
Link
LONG
Oct 22. 2018
3.27
Nov 9. 2018
3.59
14 Trading Days
9.70%
Link
Company Information
Stock Symbol
CCM
Exchange
NYSE
Company URL
http://www.concordmedical.com
Company Phone
(86)10-5825-6867
CEO
Jianyu Yang
Headquarters
-
Business Address
ROOM 2001-2002, 20TH FLOOR, TOWER A, GLOBAL TRADE CTR, 36 NORTH THIRD RING RD, DONGCHENG DISTRICT, BEIJING, CHINA 100013
Sector
Equity
Industry Category
Health Services
Industry Group
Hospitals
CIK
0001472072
About

Concord Medical Services Holding Ltd. engages in the operation of radiotherapy and diagnostic imaging centers. It operates through Network Business and Hospital Business segments. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

Description

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services. The company also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, it provides clinical support services, such as developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, the company offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as sells medical equipment. Additionally, it also engages in establishing the Beijing Proton Medical Center that would offer radiotherapy treatment options to cancer patients; and other specialty cancer hospitals that would offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2015, the company operated a network of 127 centers based in 76 hospitals, spanning 53 cities across 25 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China.